American Heart Journal
Volume 141, Issue 2, Supplement , Pages S1-S11, February 2001

The smooth muscle cell membrane during atherogenesis: A potential target for amlodipine in atheroprotection☆☆☆

Wynnewood and Philadelphia, Pa; Bethesda, Md; and Charlottesville, Va

From the aDivision of Vascular Biology, Lankenau Medical Research Center, Wynnewood, and Department of Biochemistry and Molecular Pharmacology, Thomas Jefferson University School of Medicine, Philadelphia. bNational Institutes of Health, Bethesda. cDivision of Medicine, University of Virginia School of Medicine, Charlottesville

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported in part by National Institutes of Health grants HL-66273 and HL-51538 (T.N.T.) and grants from the American Heart Association (L.L.K.), The Pfizer Pharmaceutical Group, the John S. Sharpe Research Foundation, and the Baylis Family Endowment.

☆☆ Reprint requests: Thomas N. Tulenko, PhD, Director, Division of Vascular Biology, Lankenau Medical Research Center, 100 Lancaster Ave, Wynnewood, PA 19095. E-mail: tulenkot@MLHS.org

PII: S0002-8703(01)70037-3

American Heart Journal
Volume 141, Issue 2, Supplement , Pages S1-S11, February 2001

Article Tools

* Image Usage & Resolution